Phase I/II Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple Myeloma
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Venetoclax (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 16 Mar 2018 Planned initiation date changed from 28 Feb 2018 to 28 Nov 2018.
- 05 Feb 2018 Planned initiation date changed from 30 Jan 2018 to 28 Feb 2018.
- 22 Jan 2018 New trial record